A radically different approach to cancer
Jupiter Therapeutics is on a mission to create a disruptive new drug class that will fundamentally shift the approach to cancer immunotherapy. At the heart of their story was their people who have a deep passion for science and saving lives. We helped the Executive team at Jupiter Therapeutics not only pitch their product, but their people during their seed fundraising round.
We were so excited to get the call from Jupiter when they secured their $50M round of seed funding as a result of the pitch we helped them develop.